The relevance of molecular diagnostics in the practice of surgical pathology

Bibliography

• Watson JD, Crick FH. Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature 1953;171(4356):737-8
   PubMed Web of Science ®Google Scholar
• Fletcher L. Roche leads molecular diagnostics charge. Nature Biotechnol 2002;20:6-7
   PubMedGoogle Scholar
• Salto-Tellez M. Molecular Histopathology: Diagnostic Utility and Translational Research. Austral-Asian J Cancer 2006;5(1):267-72
   Web of Science ®Google Scholar
• Salto-Tellez M, Koay ESC. Molecular diagnostic cytopathology: definitions, scope and clinical utility. Cytopathol 2004;15(5):252-5
   PubMed Web of Science ®Google Scholar
• Ross JS, Fletcher JA. HER-2/neu (c-erb-B2) gene and protein in breast cancer. Am J Clin Pathol 1999;112:S53-67
   PubMed Web of Science ®Google Scholar
• Zhang DH, Salto-Tellez M, Putti TC, et al. Evaluation of HER-2/neu Oncogene Status in Breast Tumors on Tissue Microarrays. Hum Pathol 2003;34:362-8
   PubMed Web of Science ®Google Scholar
• van't Veer LJ, Bernards R. Enabling personalized cancer medicine through analysis of gene-expression patterns. Nature 2008;452:564-70
   PubMed Web of Science ®Google Scholar
• Bagg A, Kallakury BV. Molecular pathology of leukemia and lymphoma. Am J Clin Pathol 1999;112:S76-92
   PubMed Web of Science ®Google Scholar
• Bennicelli JL, Barr FG. Genetics and the biologic basis of sarcomas. Curr Opin Oncol 1999;11: 267-74
   PubMed Web of Science ®Google Scholar
• Smith JS, Alderete B, Minn Y, et al. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene 1999;15(18):4144-52
   Google Scholar
• Lièvre A, Bachet JB, Le Corre D, et al. KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. Cancer Res 2006;66(8):3992-5
   PubMed Web of Science ®Google Scholar
• Boland CR. Hereditary nonpolyposis colorectal cancer. In Vogelstein B and Kinzler KW, editors. The Genetic Basis of Human Cancer, McGraw-Hill, 2002
   Google Scholar
• Salto-Tellez M, Lee SC, Chiu LL, et al. Microsatellite instability in colorectal cancer – considerations for molecular diagnosis and high-throughput screening of archival tissues. Clin Chem 2004;50:1082-6
   PubMed Web of Science ®Google Scholar
• Tan YH, Liu Y, Eu KW, et al. Detection of BRAF V600E mutation by pyrosequencing. Pathol 2008;40(3):295-8
   PubMed Web of Science ®Google Scholar
• Bussey HJ, Veale AM, Morson BC. Genetics of gastrointestinal polyposis Gastroenterol 1978;74(6):1325-30
   PubMed Web of Science ®Google Scholar
• Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004;350:2129-39
   PubMed Web of Science ®Google Scholar
• Paez JG, Janne PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004;304:1497-500
   PubMed Web of Science ®Google Scholar
• Lasota J, Jasinski M, Sarlomo-Rikala M, et al. Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. Am J Pathol 1999;154:53-60
   PubMed Web of Science ®Google Scholar
• Heinrich MC, Corless CL, Demetri GD, et al. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 2003;21:4342-9
   PubMed Web of Science ®Google Scholar
• Mongtgomery E, Argani P, Hicks JL, et al. Telomere lengths of translocation-associated and nontranslocation-associated sarcomas differ dramatically. Am J Pathol 2004;164(5):1523-9
   PubMedGoogle Scholar
• Ulaner GA, Hoffman AR, Otero J, et al. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas. Genes Chromosomes Cancer 2004;41:155
   PubMed Web of Science ®Google Scholar
• Khoury JD. Ewing sarcoma family of tumors. Adv Anat Pathol 2005;12:212-20
   PubMed Web of Science ®Google Scholar
• Sandberg AA, Bridge JA. Updates on cytogenetics and molculear genetics of bone and soft tissue tumors: Ewing sarcoma and peripheral primitive neuroectodermal tumors. Cancer Genet Cytogenet 2000;123:1-26
   PubMed Web of Science ®Google Scholar
• Hahn HP, Fletcher CD. The role of cytogenetics and molecular genetics in soft tissue tumour diagnosis – a realistic appraisal. Curr Diagn Pathol 2005;11:361-70
   Google Scholar
• Sirvent N, Coindre JM, Maire G, et al. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR. Am J Surg Pathol 2007;31(10):1476-89
   PubMed Web of Science ®Google Scholar
• Tamura G, Sasou S, Kudoh S, et al. Primitive neuroectodermal tumor of the breast: immunohistochemistry and fluorescence in situ hybridization. Pathol Int 2007;57(8):509-12
   PubMed Web of Science ®Google Scholar
• Athale UH, Shurtleff Sa, Jenkins JJ, et al. Use of reverse transcriptase polymerase chain reaction for diagnosis and staging of alveolar rhabdomyosarcoma, Ewing sarcoma family of tumors, and desmoplastic small round cell tumor. J Pediatr Hematol Oncol 2001;23(2):99-104
   PubMed Web of Science ®Google Scholar
• Ladanyi M, Antonescu CR, Leung DH, et al. Impact of SYT-SSX fusion type on the clinical behvior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res 2002;62:135-40
   PubMed Web of Science ®Google Scholar
• de Alava E, Kawai A, Healey JH, et al. EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J Clin Oncol 1998;16:1248-55
   PubMed Web of Science ®Google Scholar
• Guillous L, Coindre JM, Bonichon F, et al. Histologic grade, not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis. J Clin Oncol 2004;22(20):4040-50
   PubMed Web of Science ®Google Scholar
• Ginsberg JP, de Alava E, Ladanyi M, et al. EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma. J Clin Oncol 1999;17:1809-14
   PubMed Web of Science ®Google Scholar
• Sorensen PH, Lynch JC, Qualman SJ, et al. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group. J Clin Oncol 2002;20:2672-9
   PubMed Web of Science ®Google Scholar
• Oliveira AM, Fletcher CD. Molecular prognostication for soft tissue sarcomas: are we ready yet? J Clin Oncol 2004;22:4031-4
   PubMed Web of Science ®Google Scholar
• Lannon CL, Sorensen PH. ETV6-NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages. Semin Cancer Biol 2005;15(3):215-23
   PubMed Web of Science ®Google Scholar
• Rossi S, Szuhai K, Ijszenga M, et al. EWSR1-CREB1 and EWSR1-ATF1 Fusion genes in Angiomatoid Fibrous Histiocytoma. Clin Cancer Res 2007;13(24):7322-8
   PubMed Web of Science ®Google Scholar
• Antonescu CR, Dal Cin P, Nafa K, et al. EWSR1-CREB1 is the predominant gene fusion in Angiomatoid Fibrous Histiocytoma. Genes Chromosomes Cancer 2007;46(12):1051-60
   PubMed Web of Science ®Google Scholar
• Antonescu CR, Nafa K, Segal NH, et al. EWS-CREB1: A recurrent variant fusion in clear cell sarcoma – association with gastrointestinal location and absence of melanocytic differentiation. Clin Cancer Res 2006;12:5356-62
   PubMed Web of Science ®Google Scholar
• Lazar A, Abruzzo LV, Pollock RE, et al. Molecular diagnosis of sarcomas: Chromosomal translocations in sarcomas. Arch Pathol Lab Med 2006;130:1199-207
   PubMed Web of Science ®Google Scholar
• Cossman J, Fend F, Staudt LM, et al. Application of molecular genetics to the diagnosis and classification of malignant lymphoma. In Knowles D (ed) Neoplastic Hematopathology, Edition Philadelphia: Lippincott: Williams & Wilkins 2001;365-90
   Google Scholar
• Merker J, Arber D. Molecular diagnostics of non-Hodgkin lymphoma. Expert Opinion on Medical Diagnostics 2007;1:47-63
   PubMedGoogle Scholar
• Campo E, van de Rijn M. Symposium 30. Molecular diagnosis of lymphoma. Histopathol 2002;41: 506-25
   Google Scholar
• Jaffe ES, Harris NL, Stein H, Vardiman JW. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press 2001
   Google Scholar
• Harris NL, Stein H, Coupland SE, et al. New approaches to lymphoma diagnosis. Hematology/the Education Program of the American Society of Hematology. Am Soc Hematol Edu Program 2001;194-220
   PubMedGoogle Scholar
• Bagg A. Molecular diagnosis in lymphoma. Curr Hematol Reports 2005;4:313-23
   PubMedGoogle Scholar
• Arber DA. Molecular diagnostic approach to non-Hodgkin's lymphoma. J Mol Diagn 2000;2:178-90
   PubMed Web of Science ®Google Scholar
• Pan LX, Diss TC, Isaacson PG. The polymerase chain reaction in histopathology. Histopathology 1995;26:201-17
   PubMed Web of Science ®Google Scholar
• Wan JH, Sykes PJ, Orell SR, et al. Rapid method for detecting monoclonality in B cell lymphoma in lymph node aspirates using the polymerase chain reaction. J Clin Pathol 1992;45:420-3 (Erratum: J Clin Pathol 1992;1945:1124)
   PubMed Web of Science ®Google Scholar
• Alkan S, Lehman C, Sarago C, et al. Polymerase chain reaction detection of immunoglobulin gene rearrangement and bcl-2 translocation in archival glass slides of cytologic material. Diagn Mol Pathol 1995;4:25-31
   PubMed Web of Science ®Google Scholar
• Spagnolo D, Ellis D, Juneja S, et al. The role of molecular studies in lymphoma diagnosis: a review. Pathology 2004;36:19-44
   PubMed Web of Science ®Google Scholar
• Langerak AW, Molina TJ, Lavender FL, et al. Polymerase chain reaction-based clonality testing in tissue samples with reactive lymphoproliferations: usefulness and pitfalls. A report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2007;21:222-9
   PubMed Web of Science ®Google Scholar
• Brady SP, Magro CM, Diaz-Cano SJ, et al. Analysis of clonality of atypical cutaneous lymphoid infiltrates associated with drug therapy by PCR/DGGE. Hum Pathol 1999;30:130-6
   PubMed Web of Science ®Google Scholar
• Nihal M, Mikkola D, Horvath N, et al. Cutaneous lymphoid hyperplasia: a lymphoproliferative continuum with lymphomatous potential. Hum Pathol 2003;34:617-22
   PubMed Web of Science ®Google Scholar
• Schwab RSP, Manavalan JS, Weksler ME, et al. Even J. Expanded CD4+ and CD8+ T cell clones in elderly humans. J Immunol 1997;158:4493-9
   PubMed Web of Science ®Google Scholar
• van Dongen JJ, Langerak AW, Brüggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003;17:2257-317
   PubMed Web of Science ®Google Scholar
• Szczepanski T P-WM, Langerak AW, van Dongen JJ. Unusual immunoglobulin and T-cell receptor gene rearrangement patterns in acute lymphoblastic leukemias. Curr top microbiol Immunol 1999;246:205-15
   PubMed Web of Science ®Google Scholar
• Brüggemann M, White H, Gaulard P, et al. Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936. Leukemia 2007;21:215-21
   PubMed Web of Science ®Google Scholar
• Evans PA, Pott C, Groenen PJ, et al. Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia 2007;21:207-14
   PubMed Web of Science ®Google Scholar
• van Krieken JH, Langerak AW, Macintyre EA, et al. Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia 2007;21:201-6
   PubMed Web of Science ®Google Scholar
• Liu H, Bench AJ, Bacon CM, et al. A practical strategy for the routine use of BIOMED-2 PCR assays for detection of B- and T-cell clonality in diagnostic haematopathology. Br J Haematol 2007;138:31-43
   PubMed Web of Science ®Google Scholar
• Vega F, Medeiros LJ. Chromosomal translocations involved in non-Hodgkin lymphomas. Arch Pathol Lab Med 2003;127:1148-60
   PubMed Web of Science ®Google Scholar
• Ventura RA, Martin-Subero JI, Jones M, et al. FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. J Mol Diagn 2006;8:141-51
   PubMed Web of Science ®Google Scholar
• Falini B, Mason DY. Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry. Blood 2002;99:409-26
   PubMed Web of Science ®Google Scholar
• Hasserjian RP, Harris NL. NK-cell lymphomas and leukemias: a spectrum of tumors with variable manifestations and immunophenotype. Am J Clin Pathol 2007;127:860-8
   PubMed Web of Science ®Google Scholar
• Staudt LM. Molecular diagnosis of the hematologic cancers. N Engl J Med 2003;348:1777-85
   PubMed Web of Science ®Google Scholar
• Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002;346:1937-47
   PubMed Web of Science ®Google Scholar
• Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-11
   PubMed Web of Science ®Google Scholar
• Hummel M, Bentink S, Berger H, et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 2006;354:2419-30
   PubMed Web of Science ®Google Scholar
• Jonsen AR, Durfy SJ, Burke W, et al. The advert of the ‘unpatients.’ Nature Med 1996;2:622-4
   PubMed Web of Science ®Google Scholar
• Jones R. The impact of molecular medicine on health services. Nature Med 1996;2:959-60
   PubMed Web of Science ®Google Scholar
• Bell JI. The double helix in clinical practice. Nature 2003;421:414-6
   PubMed Web of Science ®Google Scholar
• Holtzman NA, Marteau TM. Will genetics revolutionise medicine? N Engl J Med 2000;343:141-4
   PubMed Web of Science ®Google Scholar
• Etang HL. Anglo–American conference on the impact of molecular medicine on clinical practice 7–9 October 1992. J R Soc Med 1993;86(4):187-93
   Web of Science ®Google Scholar
• NIH Guide: Director's challenge towards a molecular classification of tumors 1998. Available from: http://grants.nih.gov/grants/guide/rfa-files/rfa-ca-98-027.html [Last accessed July 23, 2008]
   Google Scholar
• Salto-Tellez M. A case for integrated morphomolecular diagnostic pathologists. Clin Chem 2007;53(7):1188-90
   PubMed Web of Science ®Google Scholar
• Dey P. Time for evidence-based cytology. Cyto J 2007;4:1
   Google Scholar
• Salto-Tellez M, Zhang D, Chiu LL, et al. Immunocytochemistry versus molecular fingerprinting of metastases. Cytopathol 2003;14(4):186-90
   PubMed Web of Science ®Google Scholar